Edgewise Therapeutics, Inc. - Common Stock (EWTX)
CUSIP: 28036F105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 107,555,564
- Total 13F shares
- 118,737,861
- Share change
- +13,466,413
- Total reported value
- $1,557,153,070
- Put/Call ratio
- 129%
- Price per share
- $13.11
- Number of holders
- 177
- Value change
- +$135,315,946
- Number of buys
- 116
- Number of sells
- 81
Quarterly Holders Quick Answers
What is CUSIP 28036F105?
CUSIP 28036F105 identifies EWTX - Edgewise Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28036F105:
Top shareholders of EWTX - Edgewise Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
13D/G
3/4/5
|
Company · Director, 10%+ Owner |
14%
from 13D/G
|
15,021,721
|
$330,477,862 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
8.3%
|
8,909,091
|
$196,000,002 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
|
Company |
4.4%
from 13D/G
|
6,547,328
|
$144,041,216 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.5%
from 13D/G
|
6,485,008
|
$142,670,176 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
13D/G
|
Company |
6.9%
from 13D/G
|
6,155,940
|
$135,430,680 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.9%
|
5,282,154
|
$122,854,879 | — | 31 Mar 2025 | |
| Novo Holdings A/S |
13F
3/4/5
|
Company · 10%+ Owner |
5%
|
5,350,000
|
$117,700,000 | — | 31 Mar 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
4.1%
|
4,394,556
|
$96,680,232 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4%
|
4,294,404
|
$94,476,888 | — | 31 Mar 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.8%
|
4,101,992
|
$90,243,824 | — | 31 Mar 2025 | |
| BRAIDWELL LP |
13F
|
Company |
2.3%
|
2,458,808
|
$54,093,776 | — | 31 Mar 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.9%
|
2,078,509
|
$45,727,198 | — | 31 Mar 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.7%
|
1,852,290
|
$40,750,380 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
1,717,724
|
$37,789,928 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
1.6%
|
1,696,444
|
$37,321,768 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,655,664
|
$36,431,749 | — | 31 Mar 2025 | |
| Bellevue Group AG |
13F
|
Company |
1.3%
|
1,428,929
|
$31,436,438 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
1.3%
|
1,400,000
|
$30,800,000 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,375,742
|
$30,266,324 | — | 31 Mar 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1%
|
1,105,444
|
$24,319,768 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
1%
|
1,096,809
|
$24,129,798 | — | 31 Mar 2025 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.96%
|
1,030,161
|
$22,663,542 | — | 31 Mar 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.85%
|
917,222
|
$20,178,884 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.72%
|
779,766
|
$17,154,891 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.65%
|
695,426
|
$15,299,372 | — | 31 Mar 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.63%
|
675,000
|
$14,850,000 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.62%
|
667,499
|
$14,691,743 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.57%
|
615,118
|
$13,532,596 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
606,692
|
$13,347,224 | — | 31 Mar 2025 | |
| Foresite Capital Management VI LLC |
13F
|
Company |
0.54%
|
585,000
|
$12,870,000 | — | 31 Mar 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.53%
|
568,310
|
$12,502,820 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
521,261
|
$11,467,742 | — | 31 Mar 2025 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
0.46%
|
490,035
|
$10,780,770 | — | 31 Mar 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.4%
|
425,407
|
$9,358,954 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.38%
|
408,997
|
$8,997,934 | — | 31 Mar 2025 | |
| Peter A. Thompson |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
473,792
mixed-class rows
|
$8,933,533 | — | 16 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.37%
|
397,573
|
$8,746,606 | — | 31 Mar 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
0.37%
|
395,000
|
$8,690,000 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.36%
|
390,000
|
$8,580,000 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.35%
|
376,060
|
$8,273,320 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.34%
|
366,644
|
$8,066,168 | — | 31 Mar 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.34%
|
361,233
|
$7,947,126 | — | 31 Mar 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.32%
|
342,218
|
$7,528,796 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.29%
|
313,025
|
$6,886,550 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.28%
|
302,513
|
$6,655,286 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.28%
|
300,000
|
$6,600,000 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.27%
|
294,881
|
$6,488,000 | — | 31 Mar 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.26%
|
280,735
|
$6,176,170 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.26%
|
280,000
|
$6,160,000 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.26%
|
278,973
|
$6,137,406 | — | 31 Mar 2025 |
Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock (EWTX) as of Q2 2025
As of 30 Jun 2025,
Edgewise Therapeutics, Inc. - Common Stock (EWTX) was held by
177 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
118,737,861 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, BlackRock, Inc., Paradigm Biocapital Advisors LP, JANUS HENDERSON GROUP PLC, NOVO HOLDINGS A/S, BRAIDWELL LP, VANGUARD GROUP INC, and PERCEPTIVE ADVISORS LLC.
This page lists
177
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
190
Q2 2025 holders
177
Holder diff
-13
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.